Cherry Brian N's Form 4 filing
Atara Biotherapeutics, Inc. (ATRA) · filed Sep 4, 2026
- Accession no.
- 0000905148-26-004085
- Filed
- Sep 4, 2026, 6:20 PM ET
- Trade date
- Sep 4, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $1.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cherry Brian NCIK 0001290922 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | PPurchaseAcquired | +104,166 | $9.60 | +$999,993.6 | 166,486 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.